Families with rare disease wait years for answers. Interpretation is the bottleneck: millions of variants, scarce specialists, manual curation that doesn’t scale.
Automated variant annotation and phenotype-aware prioritisation
Transparent ACMG/AMP classification with evidence links
Human-reviewed FHIR reports into your existing workflow
Every call is evidence-linked and auditable.
A qualified reviewer signs off every result.
FHIR reports drop into your existing systems.
Outcome — Faster, more consistent diagnosis.
Anchor sites get early capability and a real say in the roadmap.